Literature DB >> 23583388

The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia.

Seong-Joon Park1, Joong-Gook Kim, Tae Gen Son, Joo Mi Yi, Nam Deuk Kim, Kwangmo Yang, Kyu Heo.   

Abstract

We studied the roles of JMJD1A and its target gene ADM in the growth of hepatocellular carcinomas (HCCs) and breast cancer cells under hypoxic conditions. Hypoxia stimulated HepG2 and Hep3B cell proliferation but had no effect on MDA-MB-231 cell proliferation. Interestingly, the JMJD1A and ADM expressions were enhanced by hypoxia only in HepG2 and Hep3B cells. Our ChIP results showed that hypoxia-induced HepG2 and Hep3B cell proliferation is mediated by JMJD1A upregulation and subsequent decrease in methylation in the ADM promoter region. Furthermore, JMJD1A gene silencing abrogated the hypoxia-induced ADM expression and inhibited HepG2 and Hep3B cell growth. These data suggest that JMJD1A might function as a proliferation regulator in some cancer cell types.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583388     DOI: 10.1016/j.bbrc.2013.03.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Retraction note to: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer.

Authors: 
Journal:  J Mol Histol       Date:  2015-12       Impact factor: 2.611

2.  Evolution and conservation of JmjC domain proteins in the green lineage.

Authors:  Yong Huang; Donghong Chen; Chunlin Liu; Wenhui Shen; Ying Ruan
Journal:  Mol Genet Genomics       Date:  2015-07-08       Impact factor: 3.291

3.  Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α.

Authors:  W Wan; K Peng; M Li; L Qin; Z Tong; J Yan; B Shen; C Yu
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 4.  Metabolic regulation of histone post-translational modifications.

Authors:  Jing Fan; Kimberly A Krautkramer; Jessica L Feldman; John M Denu
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

Review 5.  Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin.

Authors:  Kimberly A Krautkramer; Rashpal S Dhillon; John M Denu; Hannah V Carey
Journal:  Transl Res       Date:  2017-09-01       Impact factor: 7.012

6.  Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.

Authors:  T Nakatsuka; K Tateishi; Y Kudo; K Yamamoto; H Nakagawa; H Fujiwara; R Takahashi; K Miyabayashi; Y Asaoka; Y Tanaka; H Ijichi; Y Hirata; M Otsuka; M Kato; J Sakai; M Tachibana; H Aburatani; Y Shinkai; K Koike
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

7.  Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.

Authors:  Kesong Peng; Guoqiang Su; Jinmeng Ji; Xiaojia Yang; Mengmeng Miao; Pingli Mo; Ming Li; Jianming Xu; Wengang Li; Chundong Yu
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

8.  Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.

Authors:  Yixin Cai; Xiangning Fu; Yu Deng
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 6.166

9.  HIFs enhance the transcriptional activation and splicing of adrenomedullin.

Authors:  Johnny A Sena; Liyi Wang; Matthew R Pawlus; Cheng-Jun Hu
Journal:  Mol Cancer Res       Date:  2014-02-12       Impact factor: 5.852

10.  Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications.

Authors:  Danyang Ren; Huiying Li; Renqiu Li; Jianming Sun; Pin Guo; Huiyun Han; Yuehuang Yang; Jun Li
Journal:  Oncol Lett       Date:  2016-01-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.